Molecular genetics and metabolism · 2026
Resources and care structures for management of urea cycle disorders in Japan and the United States: A system-level comparison.
СтатьяОбзорСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakajima Yoko, MacLeod Erin, Hirano Konomi, Mew Nicholas Ah, Oishi Kimihiko
Аннотация
BACKGROUND: Urea cycle disorders (UCD) are rare, nutrition-dependent inborn errors of metabolism in which outcomes depend on pharmacological treatment and sustained access to specialized formulas, low-protein medical foods, and dietary counseling. System-level support for dietary management varies across countries, yet comparative analyses are scarce.
METHODS: We conducted a structured comparative analysis of dietary management systems for UCD in Japan and the United States (US) using clinical guidelines, policy documents, industry information, and professional reports. The review examined four domains: pharmacological and nutritional resources, availability of specialized formulas and low-protein medical foods, healthcare delivery and insurance, and the role of metabolic dietitians.
RESULTS: In the US, individuals with UCD generally have access to multiple nitrogen-scavenging agents, UCD-specific or functionally equivalent formulas, and diverse low-protein staple foods, with care coordinated through specialized metabolic clinics and dietitians. Coverage for medical foods and formulas varies widely, leading to substantial out-of-pocket costs and inequities. In Japan, universal health insurance, pediatric subsidy schemes, and rare disease programs provide coverage for approved pharmacological treatments and hospital-based care. However, essential amino acids (EAA)-enriched, UCD-specific formulas are unavailable, EAA preparations are prescribed off-label, low-protein foods are limited, and most dietary products are not reimbursed.
CONCLUSIONS: The US model emphasizes product diversity and multidisciplinary care within a fragmented insurance framework, whereas Japan offers universal coverage and continuity of medical care but limited structural support for dietary therapy. Integrating strengths from both systems may improve nutritional management and quality of life for individuals with UCD.
METHODS: We conducted a structured comparative analysis of dietary management systems for UCD in Japan and the United States (US) using clinical guidelines, policy documents, industry information, and professional reports. The review examined four domains: pharmacological and nutritional resources, availability of specialized formulas and low-protein medical foods, healthcare delivery and insurance, and the role of metabolic dietitians.
RESULTS: In the US, individuals with UCD generally have access to multiple nitrogen-scavenging agents, UCD-specific or functionally equivalent formulas, and diverse low-protein staple foods, with care coordinated through specialized metabolic clinics and dietitians. Coverage for medical foods and formulas varies widely, leading to substantial out-of-pocket costs and inequities. In Japan, universal health insurance, pediatric subsidy schemes, and rare disease programs provide coverage for approved pharmacological treatments and hospital-based care. However, essential amino acids (EAA)-enriched, UCD-specific formulas are unavailable, EAA preparations are prescribed off-label, low-protein foods are limited, and most dietary products are not reimbursed.
CONCLUSIONS: The US model emphasizes product diversity and multidisciplinary care within a fragmented insurance framework, whereas Japan offers universal coverage and continuity of medical care but limited structural support for dietary therapy. Integrating strengths from both systems may improve nutritional management and quality of life for individuals with UCD.